Industry complains to EU over French law pushing cheap eye drug

Sept 1 (Reuters) - Europe's pharmaceuticals industry said on Tuesday it had filed a complaint with the European Commission against a French law promoting the use of Roche's cancer drug Avastin as a cheap eye treatment.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.